Gabriel S Panayi. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antirheumatic Agents/immunologyAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyArthritis, Rheumatoid/immunologyArthritis, Rheumatoid/pathologyB-Lymphocytes/immunologyB-Lymphocytes/metabolismB-Lymphocytes/pathologyCD4-Positive T-Lymphocytes/immunologyCD4-Positive T-Lymphocytes/metabolismCD4-Positive T-Lymphocytes/pathologyHLA-DR4 Antigen/metabolismHumansInterferon-gamma/metabolismInterleukin-17/metabolismTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances： See more » Antirheumatic AgentsHLA-DR4 AntigenInterleukin-17Tumor Necrosis Factor-alphaInterferon-gamma
Year: 2011 PMID： 21498557 DOI： 10.1093/rheumatology/ker024
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580